Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- High Point, North Carolina
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 601 filings
- On EDGAR
- CIK 1641489
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 48
News 8 of 174
- 8-K Quarterly results Nov 5, 2026
- 8-K Current report on a material event Oct 6, 2026
- 8-K Quarterly results Aug 6, 2026
- 8-K Shareholder vote results Jun 29, 2026
- 8-K Other events May 13, 2026
- 8-K Quarterly results May 13, 2026
- 8-K Current report on a material event Mar 10, 2026
- 8-K Quarterly results Mar 10, 2026
Prospectuses and Registrations 8 of 33
- 424B2 Prospectus supplement for an offering May 13, 2026
- S-8 Registration statement for an employee plan May 13, 2026
- S-3 Shelf registration statement Oct 3, 2025
- S-8 Registration statement for an employee plan Sep 23, 2024
- 424B2 Prospectus supplement for an offering Apr 29, 2024
- 424B2 Prospectus supplement for an offering Apr 29, 2024
- S-3 Shelf registration statement Apr 10, 2024
- 424B5 Prospectus supplement for an offering Feb 28, 2024
Proxies 8 of 20
- DEFA14A Extra proxy material Jun 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2023
- DEF 14A Proxy statement for a shareholder vote May 2, 2022
- DEFA14A Extra proxy material Mar 18, 2021
- DEF 14A Proxy statement for a shareholder vote Mar 18, 2021
Ownership 8 of 273
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 8, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Apr 16, 2026
Other 8 of 53
- EFFECT Notice that a registration became effective Nov 24, 2025
- CORRESP Reply to SEC staff Nov 20, 2025
- EFFECT Notice that a registration became effective Apr 29, 2024
- CORRESP Reply to SEC staff Apr 25, 2024
- UPLOAD Comment letter from SEC staff Apr 16, 2024
- D Mar 7, 2024
- DEF 14C Sep 25, 2023
- PRE 14C Sep 15, 2023
Everything here comes from vTv Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.